Cargando…

Validation study of the combined repeated-dose toxicity and genotoxicity assay using gpt delta rats

Transgenic rodents carrying reporter genes to detect organ-specific in vivo genetic alterations are useful for risk assessment of genotoxicity that causes cancer. Thus, the Organization for Economic Co-operation and Development has established the guideline for genotoxicity tests using transgenic an...

Descripción completa

Detalles Bibliográficos
Autores principales: Akagi, Jun-ichi, Toyoda, Takeshi, Cho, Young-Man, Mizuta, Yasuko, Nohmi, Takehiko, Nishikawa, Akiyoshi, Ogawa, Kumiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4452153/
https://www.ncbi.nlm.nih.gov/pubmed/25683344
http://dx.doi.org/10.1111/cas.12634
_version_ 1782374257864474624
author Akagi, Jun-ichi
Toyoda, Takeshi
Cho, Young-Man
Mizuta, Yasuko
Nohmi, Takehiko
Nishikawa, Akiyoshi
Ogawa, Kumiko
author_facet Akagi, Jun-ichi
Toyoda, Takeshi
Cho, Young-Man
Mizuta, Yasuko
Nohmi, Takehiko
Nishikawa, Akiyoshi
Ogawa, Kumiko
author_sort Akagi, Jun-ichi
collection PubMed
description Transgenic rodents carrying reporter genes to detect organ-specific in vivo genetic alterations are useful for risk assessment of genotoxicity that causes cancer. Thus, the Organization for Economic Co-operation and Development has established the guideline for genotoxicity tests using transgenic animals, which may be combined with repeated-dose toxicity studies. Here, we provide evidence to support equivalence of gpt delta and wild type (WT) rats in terms of toxicological responses to a genotoxic hepatocarcinogen, N-nitrosodiethylamine (DEN), and a non-genotoxic hepatocarcinogen, di(2-ethylhexyl)phthalate (DEHP). gpt delta rats treated with DEHP showed similar increases in liver and kidney weights, serum albumin, albumin/globulin ratios, and incidence of diffuse hepatocyte hypertrophy compared to WT F344 and Sprague–Dawley (SD) rats. DEN-treated gpt delta rats showed equivalent increases in the number and area of precancerous GST-P-positive foci in the liver compared to WT rats. The livers of DEN-treated gpt delta rats also showed increased frequencies of gpt and Spi(−) mutations; such changes were not observed in DEHP-treated gpt delta rats. These results indicated that gpt delta rats (both F344 and SD backgrounds) showed comparable DEHP-induced toxicity and DEN-induced genotoxicity to those observed in WT rats. With regard to the administration period, the general toxicity of 1.2% DEHP was evident throughout the experimental period, and the genotoxicity of 10 p.p.m. DEN could be detected after 2 weeks of administration and further increased at 4 weeks. These results suggested that combined assays using gpt delta rats could detect both general toxicity and genotoxicity by the canonical 4-week administration protocol. Therefore, this assay using gpt delta rats would be applicable for risk assessment including early detection of genotoxic carcinogens and ultimately serve to reduce cancer risks in humans from environmental chemicals.
format Online
Article
Text
id pubmed-4452153
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BlackWell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-44521532015-10-05 Validation study of the combined repeated-dose toxicity and genotoxicity assay using gpt delta rats Akagi, Jun-ichi Toyoda, Takeshi Cho, Young-Man Mizuta, Yasuko Nohmi, Takehiko Nishikawa, Akiyoshi Ogawa, Kumiko Cancer Sci Original Articles Transgenic rodents carrying reporter genes to detect organ-specific in vivo genetic alterations are useful for risk assessment of genotoxicity that causes cancer. Thus, the Organization for Economic Co-operation and Development has established the guideline for genotoxicity tests using transgenic animals, which may be combined with repeated-dose toxicity studies. Here, we provide evidence to support equivalence of gpt delta and wild type (WT) rats in terms of toxicological responses to a genotoxic hepatocarcinogen, N-nitrosodiethylamine (DEN), and a non-genotoxic hepatocarcinogen, di(2-ethylhexyl)phthalate (DEHP). gpt delta rats treated with DEHP showed similar increases in liver and kidney weights, serum albumin, albumin/globulin ratios, and incidence of diffuse hepatocyte hypertrophy compared to WT F344 and Sprague–Dawley (SD) rats. DEN-treated gpt delta rats showed equivalent increases in the number and area of precancerous GST-P-positive foci in the liver compared to WT rats. The livers of DEN-treated gpt delta rats also showed increased frequencies of gpt and Spi(−) mutations; such changes were not observed in DEHP-treated gpt delta rats. These results indicated that gpt delta rats (both F344 and SD backgrounds) showed comparable DEHP-induced toxicity and DEN-induced genotoxicity to those observed in WT rats. With regard to the administration period, the general toxicity of 1.2% DEHP was evident throughout the experimental period, and the genotoxicity of 10 p.p.m. DEN could be detected after 2 weeks of administration and further increased at 4 weeks. These results suggested that combined assays using gpt delta rats could detect both general toxicity and genotoxicity by the canonical 4-week administration protocol. Therefore, this assay using gpt delta rats would be applicable for risk assessment including early detection of genotoxic carcinogens and ultimately serve to reduce cancer risks in humans from environmental chemicals. BlackWell Publishing Ltd 2015-05 2015-04-10 /pmc/articles/PMC4452153/ /pubmed/25683344 http://dx.doi.org/10.1111/cas.12634 Text en © 2015 The Authors. Cancer Science published by Wiley Publishing Asia Pty Ltd on behalf of Japanese Cancer Association. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Articles
Akagi, Jun-ichi
Toyoda, Takeshi
Cho, Young-Man
Mizuta, Yasuko
Nohmi, Takehiko
Nishikawa, Akiyoshi
Ogawa, Kumiko
Validation study of the combined repeated-dose toxicity and genotoxicity assay using gpt delta rats
title Validation study of the combined repeated-dose toxicity and genotoxicity assay using gpt delta rats
title_full Validation study of the combined repeated-dose toxicity and genotoxicity assay using gpt delta rats
title_fullStr Validation study of the combined repeated-dose toxicity and genotoxicity assay using gpt delta rats
title_full_unstemmed Validation study of the combined repeated-dose toxicity and genotoxicity assay using gpt delta rats
title_short Validation study of the combined repeated-dose toxicity and genotoxicity assay using gpt delta rats
title_sort validation study of the combined repeated-dose toxicity and genotoxicity assay using gpt delta rats
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4452153/
https://www.ncbi.nlm.nih.gov/pubmed/25683344
http://dx.doi.org/10.1111/cas.12634
work_keys_str_mv AT akagijunichi validationstudyofthecombinedrepeateddosetoxicityandgenotoxicityassayusinggptdeltarats
AT toyodatakeshi validationstudyofthecombinedrepeateddosetoxicityandgenotoxicityassayusinggptdeltarats
AT choyoungman validationstudyofthecombinedrepeateddosetoxicityandgenotoxicityassayusinggptdeltarats
AT mizutayasuko validationstudyofthecombinedrepeateddosetoxicityandgenotoxicityassayusinggptdeltarats
AT nohmitakehiko validationstudyofthecombinedrepeateddosetoxicityandgenotoxicityassayusinggptdeltarats
AT nishikawaakiyoshi validationstudyofthecombinedrepeateddosetoxicityandgenotoxicityassayusinggptdeltarats
AT ogawakumiko validationstudyofthecombinedrepeateddosetoxicityandgenotoxicityassayusinggptdeltarats